Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 24, 2015

Primary Completion Date

June 24, 2017

Study Completion Date

June 24, 2017

Conditions
Type 1 Diabetes
Interventions
DEVICE

insulin pump to inControl AP platform

Insulin from the pump is delivered according to the closed-loop algorithm fed by CGM data.

Trial Locations (1)

34295

UHMontpellier, Montpellier

Sponsors
All Listed Sponsors
collaborator

MEDBIOMED, Montpellier, France

UNKNOWN

collaborator

Jaeb Center for Health Research

OTHER

collaborator

University of Virginia

OTHER

lead

University Hospital, Montpellier

OTHER